Welcome to my blog :)

rss

Wednesday, July 3, 2013

Ayurveda the divine science of life -17














































Ayurveda the divine science of life




Botany: Kan.
t.
aka¯ri is a highly branched perennial
herb, with an irregularly shaped stem that is somewhat
woody at the base, covered in whitish hairs, with
shining yellowish prickles that are up to 1.3 cm long.
The leaves are up 5–10 cm in length and between 2.5
and 6 cm wide, ovate to elliptic, deeply lobed, covered
in whitish hairs and prickles along the midrib and
veins. The purple or blue flowers are borne in axillary
cymes, giving rise to small globose berries that are yellowish
white, with green veins, containing small yellowish
brown seeds. Kan.
t.
aka¯ri is found throughout
tropical India and Southeast Asia (Kirtikar & Basu
1935).
Part used:Whole plant, root.
Dravygun. a:
Rasa: kat.u, tikta
Vipa¯ka: kat.u
Vı¯rya: us.n.
a, ru¯ks.
a
Karma: dı ¯panapa¯cana, anulomana, kr . mighna,
jvaraghna, chedana, ka¯sahara, sva¯sahara,
mu¯travirecana, a´smaribhedana, hr . daya, a¯rtavajanana,
va¯takaphahara (Srikanthamurthy 2001, Warrier
et al 1996)
Constituents: The limited amount of chemical
research on Kan.
t.
aka¯ri has yielded the steroidal glycosides
carpesterol, indioside, -sitosterol, dioscin,
methyl protoprosapogenin A, methyl protodioscin and
protodioscin. In addition researchers have isolated the
sesquiterpene solavetivone, a novel solafuranone,
scopoletin, esculin, esculetin, N-(p-transcoumaroyl)
tyramine, and N-trans-feruloyltyramine, as well as the
alkaloids solanine, solanidine, solasonine, solamargine,
and solaurine (Chiang et al 1991, Gan et al
1993, Kapoor 1990, Syu et al 2001, Yoganarasimhan
2000).
Medical research:
Human trials: Solanum xanthocarpum and
Solanum trilobatum were demonstrated to promote
a significant improvement in the ventilatory
function of asthmatic individuals, without side
effects (Govindan et al 1999, 2004).
Toxicity: No data found.
Indications: Dyspepsia, colic, flatulence, constipation,
haemorrhoids, intestinal parasites, fever,
catarrh, cough, bronchitis, pharyngitis, asthma,
urolithiasis, oedema, skin diseases, inflammatory joint
disease, sciatica, cardiovascular disease, amenorrhoea,
dysmenorrhoea, epilepsy.
Contraindications: pittakopa.
Medicinal uses: Kan.
t.
aka¯ri is a warming, stimulating
herb, with a dı¯panapa¯cana activity that is useful
to correct digestion and remove catarrh, commonly
used in the treatment of fever (jvara), digestive weakness
and respiratory conditions. For fever with pain in
the chest Kan.
t.
aka¯ri is decocted with Goks.ura, and
taken with red rice (Sharma 2002). In the treatment of
cough the Cakradatta recommends a decoction of
Kan.
t.
aka¯ri and Harı¯takı¯, taken with honey and a
paste of Trikat.u (Sharma 2002). Similarly, a medicated
ghr. ta prepared with the fresh juice of
Kan.
t.
aka¯ri and powders of Ra¯sna¯, Bala¯, Goks.ura
and Trikat.u is used to treat the different types of
cough as well as hoarseness (Sharma 2002). In the
treatment of colic Kan.
t.
aka¯ri is decocted with Bala¯,
Punarnava¯, Goks.ura, and Br. hatı¯, taken with Hin.gu
and rock salt (Sharma 2002). In the treatment of
haemorrhoids Kan.
t.
aka¯ri is prepared as a medicated
Kan.
t.
aka¯ri, ‘thorny’
BOTANICAL NAME: Solanum xanthocarpum, S. surattense, Solanaceae
OTHER NAMES: Vya¯ghrı¯, ‘tigress’ (S); Birhatta (H); Kandangattiri,
Papparapalli (T); Yellowberried Nightshade
226 PART 2: A¯ yurvedic materia medica
ghr. ta called Simhyamr. ta ghr. ta, prepared by decocting
it along with Gud.u¯cı¯, and a smaller proportion of
Citraka, Triphala, Pu¯tika¯ bark, Indrayava,
Gambha¯ri and Vid.
an.ga (Sharma 2002). As a ‘simple’
(remedy), a decoction of Kan.
t.
aka¯ri taken with honey
is stated to be effective in all forms of dysuria and
urolithiasis (Sharma 2002). In the treatment of parasites
Kan.
t.
aka¯ri is used with antihelminthic herbs such
as Vid.
an.ga, and purgatives such as Trivr.
t.
Dosage:
Cu¯rn.
a: 3–5 g b.i.d.–t.i.d.
Kva¯tha: 30–90 mL b.i.d.–t.i.d.
REFERENCES
Chiang HC, Tseng TH, Wang CJ et al 1991 Experimental antitumor
agents from Solanum indicum L. AntiCancer Research
11(5):1911–1917
Gan KH, Lin CN, Won SJ 1993 Cytotoxic principles and their derivatives
of Formosan Solanum plants. Journal of Natural Products
56(1):15–21
Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R 1999
A pilot study on the clinical efficacy of Solanum xanthocarpum
and Solanum trilobatum in bronchial asthma. Journal of
Ethnopharmacology 66(2):205–210
Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R 2004
Further studies on the clinical efficacy of Solanum xanthocarpum
and Solanum trilobatum in bronchial asthma.
Phytotherapy Research 18(10):805–809
Kapoor LD 1990 CRC Handbook of Ayurvedic medicinal plants. CRC
Press, Boca Raton, p 305
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1759–1760
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Sharma PV 2002 Cakradatta. Sanskrit text with English translation.
Chaukhamba, Varanasi, p 4, 88, 155, 163, 257, 311
Srikanthamurthy KR 1994 Va¯gbhat.
a’s As.t.
a¯ñga Hr. dayam, vol 1.
Krishnadas Academy, Varanasi
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 233
Syu WJ, Don MJ, Lee GH, Sun CM 2001 Cytotoxic and novel compounds
from Solanum indicum. Journal of Natural Products
64(9):1232–1233
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1996 Indian medicinal
plants: a compendium of 500 species, vol 5. Orient
Longman, Hyderabad, p 164
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2: Tamil
Nadu. Self-published, Bangalore, p 505
Kapikacchu¯ , ‘monkey itcher’ 227
Botany: Kapikacchu¯ is a climbing annual with slender,
pubescent branches. The leaves are trifoliate,
attached by a long petiole up to 12 cm long, the
leaflets ovate, elliptic to rhomboid ovate, 7–15 cm
long, the terminal leaflet slightly larger, the leaf surface
pubescent above and densely covered in silverygrey
hairs below, margin entire. The purple flowers are
borne in elongated racemes of up to 30 flowers, giving
rise to curved pods with longitudinal ribs, covered in
brown or grey bristles, 5–7.5 cm long, each containing
four to six black ovoid seeds. Kapikacchu¯ is found
throughout India, Africa and Southeast Asia (Kirtikar
& Basu 1935, Warrier et al 1995).
Part used: Seeds.
Dravygun. a:
Rasa: amla, tikta, ka´sa¯ya, madhura
Vipa¯ka: guru
Vı¯rya: us.n.
a
Karma: medhya, balya, vajı ¯karan. a, va¯tapittahara
(Srikanthamurthy 2001, Warrier et al 1995).
Constituents: The most prominent constituent in
Kapikacchu¯ is L-dopa (3,4-dihydroxy-L-phenylalanine
or 3-hydroxy-L-tyrosine), present in concentrations
that range from a low of 1.81% for an accession named
M. pruriens var. utilis grown in the USA, to a high of
7.64% for an accession named M. pruriens var.
cochinchinensis grown in Bénin. It appears that
L-dopa synthesis in the various cultivars is higher in
plants grown at low latitudes, near the equator.
Researchers have also identified a number of hallucinogenic
indoles such as bufotenine, N,N-dimethyltryptamine
and other tryptamines including serotonin,
the latter of which is found in high concentrations in
the bristles on the seed pods, which can cause profound
skin irritation similar to a Nettle rash (hence the name
‘itcher of monkeys’). Other constituents include
physostigmine, cyanogenic glycosides, trypsin and
amylase inhibitors, tannins, lectins, and phytic acid.
Several alkaloids have also been identified, including
nicotine, mucunine, mucunadine, prurienine,
prurienidine, prurieninine, as well as an oil composed
of stearic, palmatic, myristic, arachidic, oleic, and
linoleic acids, phytosterols and lecithin (Burgos et al
2002, Kapoor 1990, St-Laurent et al 2002, Szabo &
Tabbet 2002, Yoganarasimhan 2000).
Medical research:
In vitro: antioxidant (Tripathi & Upadhyay 2002)
In vivo: antidiabetic (Rathi et al 2002), antivenom
(Aguiyi et al 2001)
Human trials: Used after 28 days of pañca
karma therapy, a formula comprising Mucuna
pruriens, Hyoscyamus reticulatus, Withania somnifera
and Sida cordifolia, decocted in cow’s milk,
promoted a significant improvement in symptoms
of Parkinson’s disease (Nagashayana et al 2000).
An extract of Mucuna pruriens was found to promote
statistically significant reductions in Hoehn
and Yahr Stage scores and the Unified Parkinson’s
Disease Rating Scale (UPDRS) scores in patients
with Parkinson’s disease (Manyam et al 1995).
Compared with standard L-dopa/carbidopa, 30 g of
Mucuna pruriens extract given to patients suffering
from Parkinson’s disease led to a more rapid
onset of action and longer effect without a concomitant
increase in dyskinesia (Katzenschlager
et al 2004).
Kapikacchu¯, ‘monkey itcher’
BOTANICAL NAME: Mucuna pruriens, Papilionaceae (Fabaceae)
OTHER NAMES:A¯tmagupta¯, ‘concealed self’ (S); Goncha, Kevancha, Khujani (H);
Punaikkali (T); Cowitch, Cowhage (E)
228 PART 2: A¯ yurvedic materia medica
Toxicity: A study examining the oral toxicity of
Mucuna pruriens on albino rats for 30 days showed no
toxic effect up to a dose of 600 mg/kg (Tripathi
& Upadhyay 2002). Kapikacchu¯ contains phytic acid,
which binds to minerals in the gut thereby inhibiting
their absorption, as well as lectins, which can promote
gastrointestinal upset and inflammation. Some studies
have shown GI upset to be a minor side-effect of
higher doses.
Indications: Weakness, debility, consumption, wasting,
asthenia, infertility, frigidity, spasm, tremor,
chorea, Parkisonson’s disease, dementia.
Contraindications: Pre-existing sensitivities to
legumes, inflammatory bowel disease and irritable
bowel syndrome.
Medicinal uses: Kapikacchu¯ has long been valued in
yurveda as one of the most effective vajı¯karan. a
dravyas, used in both men and women, but specifically
male sexual dysfunction, such as erectile
dysfunction, premature ejaculation and sperm
pathologies. To this end Kapikacchu¯ is often combined
with botanicals such as Goks.ura and A´svagandha¯ for
men, and with Goks.ura and ´Sata¯varı¯ in the treatment
of frigidity and leucorrhea in women. As an allpurpose
vajı¯karan. a rasa¯yana the Bha¯vapraka¯´sa
recommends a formulation for a vat.
ı¯ (‘pill’) called
Va¯na¯rı¯ vat.ı¯, made by decocting one kud.ava (approx.
192 g) of the seed-pods in one prastha (approx. 768
mL) of cow’s milk until the milk becomes thick. The
seeds are then removed from the pods and pounded,
fried in ghr. ta, and mixed with twice their weight in
jaggery. The resultant preparation is then rolled into
small pills and dosed at about 3–4 g, twice daily
(Srikanthamurthy 2000). Kapikacchu¯ is also widely
used in the treatment of almost any va¯ta disorder used
to strengthen the mind and body in debilitated states,
used in combination with botanicals such as A´svagandha
¯, A¯malakı¯, Bra¯hmı¯ and Jat.
a¯ma¯msı¯. It is an
important remedy in many spasmodic afflictions, both
topically and internally, including paralysis, hemiplegia
and kampava¯ta (paralysis agitans). In the treatment
of Parkinson’s disease Kapikacchu¯ has shown
benefit in clinical trials, used singly or in combination
with botanicals such as A´svagandha¯, Bala¯, and
Pa¯rasikayava¯nı¯. Mixed with equal parts powders of
Arjuna and Na¯gabala¯, Kapikacchu¯ seed powder is
fried in ghr. ta and cooked with milk and sugar to make
Kakubha¯di modaka, used in the treatment of cough,
bronchitis and consumption (Sharma 2002). As a
member of the Fabaceae Kapikacchu¯ contains many
of the same constituents found in beans that can promote
gastrointestinal distress, and thus measures
should be taken to include herbs with a pa¯cana activity
in formulation, such as ´Su¯n.t.
hı¯. The seeds are traditionally
referred to as an antivenomous remedy against
scorpion sting and snakebite, which has been validated
by modern research. The hairs scraped from the pods
are traditionally used topically as an irritant in fainting,
and internally as a decoction in the treatment of
intestinal parasites.
Dosage:
Cu¯rn.
a: freshly powdered dried seed, 3–10 g
b.i.d.–t.i.d.
Tincture: crushed seeds, 1:4, 25% alcohol, 3–15 mL
REFERENCES
Aguiyi JC, Guerranti R, Pagani R, Marinello E 2001 Blood chemistry
of rats pretreated with Mucuna pruriens seed aqueous
extract MP101UJ after Echis carinatus venom challenge.
Phytotherapy Research 15(8):712–714
Burgos A, Matamoros I, Toro E 2002 Evaluation of velvet bean
(Mucuna pruriens) meal and Enterolobium ciclocarpum fruit
meal as replacements for soybean meal in diets for dualpurpose
cows. In: Flores M, Eilittä M, Myhrman R et al (eds)
Food and feed from Mucuna: current uses and the way forward.
Cover Crops Internal Clearinghouse (CIDICCO),
Tegucigalpa, Honduras, p 228–237
Kapoor LD 1990 CRC handbook of Ayurvedic medicinal plants.
CRC Press, Boca Raton, p 236
Katzenschlager R, Evans A, Manson A et al 2004 Mucuna pruriens
in Parkinson’s disease: a double blind clinical and pharmacological
study. Journal of Neurology, Neurosurgery and
Psychiatry 75(12):1672–1677
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 778–780
Manyam BV 1995 An alternative medicine treatment for
Parkinson’s disease: results of a multicenter clinical trial.
HP–200 in Parkinson’s Disease Study Group. Journal of
Alternative and Complementary Medicine 1(3):249–255
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Nagashayana N, Sankarankutty P, Nampoothiri MR et al 2000
Association of L-DOPA with recovery following Ayurveda medication
in Parkinson’s disease. Journal of the Neurological
Sciences 176(2):124–127
Rathi SS, Grover JK, Vats V 2002 The effect of Momordica charantia
and Mucuna pruriens in experimental diabetes and their
effect on key metabolic enzymes involved in carbohydrate
metabolism. Phytotherapy Research 16(3):236–243
Kapikacchu¯ , ‘monkey itcher’ 229
Sharma PV 2002 Cakradatta: Sanskrit text with English translation.
Chaukhamba, Varanasi, p 134
Srikanthamurthy KR 2000 Bha¯vapraka¯´sa of Bha-vami´sra, vol 2.
Krishnadas Academy, Varanasi, p 834
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 248
St-Laurent L, Livesey J, Arnason JT, Bruneau A 2002 Variation in
L-dopa concentration in accessions of Mucuna pruriens (L.)
DC. and in Mucuna brachycarpa Rech. In: Flores M, Eilittä M,
Myhrman R et al (eds) Food and feed from Mucuna: current
uses and the way forward. Cover Crops Internal
Clearinghouse (CIDICCO), Tegucigalpa, Honduras, p 352–374
Szabo NJ, Tebbett IR 2002 The chemistry and toxicity of Mucuna
species. In: Flores M, Eilittä M, Myhrman R et al (eds) Food and
feed from Mucuna: current uses and the way forward. Cover
Crops Internal Clearinghouse (CIDICCO), Tegucigalpa,
Honduras, p 120–141
Tripathi YB, Upadhyay AK 2002 Effect of the alcohol extract of the
seeds of Mucuna pruriens on free radicals and oxidative stress
in albino rats. Phytotherapy Research 16(6):534–538
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1995 Indian
medicinal plants: a compendium of 500 species, vol 4. Orient
Longman, Hyderabad, p 68
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2: Tamil
Nadu. Self-published, Bangalore, p 366
230 PART 2: A¯ yurvedic materia medica
Botany: Kat.uka is a small pubescent perennial herb
that spreads by elongated creeping rhizomes, about the
thickness of the little finger. The leaves are basal, leathery,
spatulate in shape with serrated margins, the tip
rounded, about 5–10 cm in length. The white or bluish
flowers are borne on stems as a terminal spicate raceme,
longer than the leaves and for the most part naked. The
fruits are ovoid capsules. Kat.uka is native to alpine
regions in the Himalayas, from Kashmir to Sikkim,
2700 to 4500 m in elevation. Unregulated overharvesting
has made Kat.uka a threatened species in Nepal and
is listed in CITES Appendix II (Kirtikar & Basu 1935,
MOPE 2001, Warrier et al 1995).
Part used: Rhizome. Two varieties are described:
a white variety, which is intensely bitter, and a black
variety, which is less so (Kirtikar & Basu 1935).
Dravygun. a:
Rasa: tikta, kat.u
Vipa¯ka: kat.u
Vı¯rya: ´sita, ru¯ks.
a
Karma: dı¯panapa¯cana, bhedana, kr . mighna,
jvaraghna, ka¯sahara, sva¯sahara, raktaprasa¯dana,
kus.t.
haghna, pittakaphahara (Srikanthamurthy
2001, Warrier et al 1995).
Constituents: The best studied constituents of
Kat.uka are its glycosides, such as picrorhizin, which is
stated to be its bitter-tasting principle, and specifically,
a glycosidal fraction referred to as picroliv, standardised
to contain a mixture of at least 60% kutkoside and
the iridoid glycoside picroside I. Since the isolation of
picroliv, however, a number of related iridoid glycosides
have been described, including picrosides II, III
and IV, pikuroside and 6-feruloyl catalpol. Other constituents
isolated from Kat.uka root include a group of
phenylethanoid glycosides called scrosides A–C, the
phenol glycoside androsin, the catechol apocynin, nine
cucurbitacin glycosides, D-mannitol, kutkiol, kutkisterol,
and glucosidovanilloyl glucose (Duke 2002, Jia
et al 1999, Li et al 1998, Kapoor 1990, Smit et al
2000, Stuppner & Wagner 1989).
Medical research:
In vitro: anti-HBsAg (Mehrotra et al 1990), antioxidant
(Chander et al 1992), anti-inflammatory
(Engels et al 1992).
In vivo: hepatoprotective (Chander et al 1998,
Dwivedi et al 1992, Jeena et al 1999, Mittal 1998,
Rajeshkumar & Kuttan 2000, Santra et al 1998,
Saraswat et al 1997, 1999, Singh et al 1992),
immunostimulant (Puri et al 1992, Sharma et al
1994), anti-anaphylaxis (Baruah et al 1998,
Dorsch et al 1991), antimicrobial (Mittal 1998;
Chander et al 1998), antioxidant (Gaddipati et al
1999, Rastogi et al 2001, Singh et al 2000), cardioprotective
(Senthil Kumar et al 2001), antidiabetic
(Joy & Kuttan 1999), antitumour (Joy et al
2000, Rajeshkumar & Kuttan 2001).
Human trials: Kat.uka root powder promoted
significant improvements in serum bilirubin, SGOT
and SGPT compared to placebo in patients diagnosed
with acute viral hepatitis (HBsAg negative)
(Vaidya et al 1996).
Toxicity: The potential toxicity of Kat.uka has not
been well studied, but from a survey of the literature,
both ancient and modern, Kat.uka appears to be relatively
non-toxic. Duke (2002) reports that the curcubitans
may be responsible for ‘ . . . diarrhea, gas and
griping’, and have an oral LD50 of 10.9 mg/kg in mice.
Kat.uka, ‘pungent’
BOTANICAL NAME: Picrorrhiza kurroa, Scrophulariaceae
OTHER NAMES: Kutki (H); Katukurogani (T); Picrorrhiza (E); Hu huang lian (C)
Kat.uka, ‘pungent’ 231
Indications: Bilious dyspepsia, hepatic torpor, constipation,
fever, cough, bronchitis, asthma, allergies,
burning sensation, inflammatory skin conditions,
infection, jaundice, hepatitis, cirrhosis, oedema,
inflammatory joint disease, cancer.
Contraindications: In large doses Kat.uka may act as
a purgative, and should be avoided during pregnancy.
In addition, the exceptionally cooling and drying
nature of Kat.uka make it contraindicated in
va¯takopa, without utilising proper adjuncts in formulation.
Mills & Bone (2000) state that Kat.uka acts as
a potent immunostimulant, and thus may be contraindicated
in autoimmune disease and immune dysregulation.
Medicinal uses: Kat.uka is an archetypal bitter herb
in A¯ yurvedic medicine, with a linear relationship
between its intensely bitter taste (tikta rasa) and its
cold and dry energies (´sita ru¯ks.
a vı¯rya). Thus
Kat.uka is indicated primarily in pitta (hot) and
kapha (wet) conditions, and should be used only in
small doses or for short periods of time in va¯ttika
states. Why exactly Kat.uka is called ‘pungent’ is not
entirely clear, as kat.u is at best an anu rasa, or secondary
taste – in some texts Kat.uka is classified as
having an us.n.
a vı¯rya, and this may explain the discrepancy.
As a bitter herb, Kat.uka is obviously important
in liver and spleen dysfunction, used in simple
states of hepatic torpor and bilious dyspepsia, as well
as in hepatosplenomegaly, drug-induced liver injury,
viral hepatitis, jaundice, cirrhosis and liver flukes,
usually in combination with aromatic dı¯panapa¯cana
herbs to reduce any possible griping. In the treatment
of viral hepatitis Kat.uka may be of benefit when combined
with other antiviral botanicals such as
Bhu¯nimba, Wu wei zi (Schizandra chinensis), St John’s
Wort (Hypericum perforatum) and Osha (Ligusticum
porteri). In the treatment of jaundice and other liver
disorders, the Cakradatta recommends a decoction of
Kat.uka with equal parts Triphala, Gud.u¯cı¯, Vaca¯,
Kira¯tatikta¯ and Nimba, taken with honey
(Sharma 2002). Kat.uka is also used more generally
in a variety of digestive disorders, such as constipation,
in which it is used in small amounts combined
with dı¯panapa¯cana remedies such as Triphala,
Hingvatsak and saindhava. In the treatment of malabsorption
(grahan. ı¯), with bloody diarrhoea and
haemorrhoids, the Cakradatta recommends a cu¯rn.
a
called Na¯gara¯dya cu¯rn.
a composed of equal parts
Kus.
t.
ha, ´Su¯n.t.
hı¯, purified Ativis.a¯, Mustaka,
Dha¯taki, Rasa¯ñjana, Kut.aja, Bilva and Pa¯t.ha¯,
mixed with honey and taken with peya (rice water)
(Sharma 2002). In the treatment of udara (intestinal
parasites) and secondary anaemia the Cakradatta
recommends Kat.uka decocted with equal parts
Punarnava¯, Nimba, Pat.
ola, ´Su¯n.t.
hı¯, Gud.u¯cı¯,
Devada¯ru and Harı¯takı¯. This remedy is also stated to
be useful in cough and dyspnoea (Sharma 2002). As a
cooling, anti-inflammatory remedy, Kat.uka is important
in pittakopa conditions, with symptoms of heat
and burning, as well as in inflammatory and infectious
skin conditions. In the treatment of paittika
jvara (fever) for example, the Cakradatta recommends
that Kat.uka be decocted with equal parts
Indrayava, Kat.phala, Mustaka, and Pa¯t.ha¯
(Sharma 2002). In the treatment of inflammatory
joint diseases such as gout, particularly with symptoms
of burning and heat, Kat.uka is combined with
equal parts Pat.
ola, ´Sata¯varı¯, Triphala and Gud.u¯cı¯
(Sharma 2002). Kat.uka is also important in typically
kaphaja conditions such as cough and bronchitis, in
combination with herbs such as Bibhı¯taka, Va¯saka,
and Yas.t.
imadhu, and usually with dı¯panapa¯cana
remedies such as Trikat.u to offset its cooling energy.
In the treatment of oedema Kat.uka is mentioned in
formulation with botanicals such as Harı¯takı¯,
Devada¯ru, and Pippalı¯. More recently, Kat.uka has
been used by Western herbalists as an potent
immunostimulant, in combination with herbs such as
Purple Coneflower (Echinacea angustifolia) and
Bhu¯nimba, in the treatment of chronic viral infection
and immunodeficiency.
Dosage:
Cu¯rn.
a: dried rhizome, 2–3 g b.i.d.–t.i.d.
Tincture: dried rhizome, 1:4, 60% alcohol,
1–3 mL
REFERENCES
Baruah CC, Gupta PP, Nath A et al 1998 Anti-allergic and antianaphylactic
activity of picroliv–a standardised iridoid glycoside
fraction of Picrorhiza kurroa. Pharmacological Research
38(6):487–492
Chander R, Kapoor NK, Dhawan BN 1992 Picroliv, picroside-I and
kutkoside from Picrorhiza kurrooa are scavengers of superoxide
anions. Biochemical Pharmacology 44(1):180–183
232 PART 2: A¯ yurvedic materia medica
Chander R, Singh K, Visen PK et al 1998 Picroliv prevents oxidation
in serum lipoprotein lipids of Mastomys coucha infected with
Plasmodium berghei. Indian Journal of Experimental Biology
36(4):371–374
Dorsch W, Stuppner H, Wagner H et al 1991 Anti-asthmatic effects
of Picrorhiza kurroa: androsin prevents allergen- and PAFinduced
bronchial obstruction in guinea pigs. International
Archives Of Allergy And Applied Immunology
95(2–3):128–133
Dwivedi Y, Rastogi R, Garg NK, Dhawan BN 1992 Effects of picroliv,
the active principle of Picrorhiza kurroa, on biochemical
changes in rat liver poisoned by Amanita phalloides. Zhongguo
Yao Li Xue Bao 13(3):197–200
Duke JA 2002 Handbook of medicinal herbs, 2nd edn. CRC Press,
Boca Raton, p 568
Engels F, Renirie BF, Hart BA et al 1992 Effects of apocynin, a drug
isolated from the roots of Picrorhiza kurroa, on arachidonic
acid metabolism. FEBS Letters 305(3):254–256
Gaddipati JP, Mani H, Banaudha KK et al 1999 Picroliv modulates
the expression of insulin-like growth factor (IGF)-I, IGF-II and
IGF-I receptor during hypoxia in rats. Cellular and Molecular
Life Sciences 56(3–4):348–355
Jeena KJ, Joy KL, Kuttan R 1999 Effect of Emblica officinalis,
Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine
induced hepatocarcinogenesis. Cancer Letters
136(1):11–16
Jia Q, Hong MF, Minter D 1999 Pikuroside: a novel iridoid from
Picrorhiza kurroa. Journal of Natural Products 62(6):901–903
Joy KL, Kuttan R 1999 Anti-diabetic activity of Picrorrhiza kurroa
extract. Journal of Ethnopharmacology 67(2):143–8
Joy KL, Rajeshkumar NV, Kuttan G, Kuttan R 2000 Effect of
Picrorrhiza kurroa extract on transplanted tumors and chemical
carcinogenesis in mice. Journal of Ethnopharmacology
71(1–2):261–266
Kapoor LD 1990 CRC handbook of Ayurvedic medicinal plants. CRC
Press, Boca Raton, p 263
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1825–1826
Li JX, Li P, Tezuka Y, Namba T, Kadota S 1998 Three phenylethanoid
glycosides and an iridoid glycoside from Picrorhiza scrophulariiflora.
Phytochemistry 48(3):537–542
Mehrotra R, Rawat S, Kulshreshtha DK 1990 In vitro studies on the
effect of certain natural products against hepatitis B virus.
Indian Journal of Medical Research 92:133–8
Mills S, Bone K 2000 Principles and practice of phytotherapy.
Churchill Livingstone, London, p 154
Mittal N, Gupta N, Saksena S 1998 Protective effect of Picroliv from
Picrorhiza kurroa against Leishmania donovani infections in
Mesocricetus auratus. Life Sciences 63(20):1823–1834
MOPE 2001 Nepal’s State of the Environment. Ministry of
Population and Environment, Kathmandu p annex 1–2.
Available:
http://www.mope.gov.np/environment/state2001.php
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Puri A, Saxena RP, Sumati et al 1992 Immunostimulant activity of
Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, and
its protective action against Leishmania donovani infection in
hamsters. Planta Medica 58(6):528–532
Rajeshkumar NV, Kuttan R 2000 Inhibition of N-nitrosodiethylamine-
induced hepatocarcinogenesis by Picroliv. Journal of
Experimental and Clinical Cancer Research 19(4):459–465
Rajeshkumar NV, Kuttan R 2001 Protective effect of Picroliv, the
active constituent of Picrorhiza kurroa, against chemical
carcinogenesis in mice. Teratogenesis, Carcinogenesis, and
Mutagenesis 21(4):303–313
Rastogi R, Srivastava AK, Rastogi AK 2001 Long term effect of aflatoxin
B(1) on lipid peroxidation in rat liver and kidney: effect of
picroliv and silymarin. Phytotherapy Research 15(4):307–310
Santra A, Das S, Maity A et al 1998 Prevention of carbon tetrachloride-
induced hepatic injury in mice by Picrorhiza kurrooa.
Indian Journal of Gastroenterology 17(1):6–9
Saraswat B, Visen PK, Patnaik GK, Dhawan BN 1997 Protective
effect of picroliv, active constituent of Picrorhiza kurrooa,
against oxytetracycline induced hepatic damage. Indian Journal
of Experimental Biology 35(12):1302–1305
Saraswat B, Visen PK, Patnaik GK, Dhawan BN 1999 Ex vivo and in
vivo investigations of picroliv from Picrorhiza kurroa in an alcohol
intoxication model in rats. Journal of Ethnopharmacology
66(3):263–269
Senthil Kumar SH, Anandan R, Devaki T, Santhosh Kumar M 2001
Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-
induced myocardial stress in rats. Fitoterapia
72(4):402–405
Sharma ML, Rao CS, Duda PL 1994 Immunostimulatory activity of
Picrorhiza kurroa leaf extract. Journal of Ethnopharmacology
41(3):185–192
Sharma PV 2002 Cakradatta. Sanskrit text with English translation.
Chaukhamba, Varanasi, p 12, 65, 114, 234, 347
Singh AK, Mani H, Seth P et al 2000 Picroliv preconditioning protects
the rat liver against ischemia-reperfusion injury. European
Journal of Pharmacology 395(3):229–239
Singh V, Visen PK, Patnaik GK 1992 Effect of picroliv on low density
lipoprotein receptor binding of rat hepatocytes in hepatic damage
induced by paracetamol. Indian Journal of Biochemistry
and Biophysics. 29(5):428–432
Smit HF, van den Berg AJ, Kroes BH 2000 Inhibition of T-lymphocyte
proliferation by cucurbitacins from Picrorhiza scrophulariaeflora.
Journal of Natural Products 63(9):1300–1302
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 182
Stuppner H, Wagner H 1989 New cucurbitacin glycosides from
Picrorhiza kurrooa. Planta Medica 55(6):559–563
Vaidya AB, Antarkar DS, Doshi JC et al 1996 Picrorhiza kurroa
(Kutaki) Royle ex Benth as a hepatoprotective agent: experimental
and clinical studies. Journal of Postgraduate Medicine
42(4):105–108
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1995 Indian medicinal
plants: a compendium of 500 species, vol 4. Orient
Longman, Hyderabad, p 269–272
Ku¯s.ma¯n.d.
a 233
Botany: Ku¯s.ma¯n.d.
a is a large trailing plant with stout
angular stems and stiff hairs. The cordate leaves are
large, up to 12 cm in diameter, with five to seven lobes,
mostly glabrous above with stiff hairs below. The flowers
are yellow, monoecious, the male peduncle longer
than the female. The fruit is a cylindrical gourd that
grows up to 45 cm in length and can weigh up to 35 kg.
It is hairy and is covered in a waxy, chalky coating that
protects it against pests and gives it an exceptionally
long shelf-life. Ku¯s.ma¯n.d.
a is found throughout Asia in
tropical regions, cultivated as both a food and medicine
(Kirtikar & Basu 1935, Warrier et al 1994).
Part used: Unripe, maturing and ripened fruit, seeds.
Dravygun. a:
Rasa: madhura
Vipa¯ka: guru (unripe fruit), laghu (ripe fruit)
Vı¯rya: ´sita, ru¯ks.
a (unripe fruit); ripe fruit has an
almost neutral vı ¯rya
Karma: unripe fruit is bhedana, jvaraghna,
raktaprasa¯dana, ´son. itastha¯pana, da¯hapra´samana,
vajı ¯karan. a, balya, va¯tapittahara; maturing fruit is
kaphakopa; mature fruit and seed is dı ¯pana,
mu¯travirecana, medhya, tridos.aghna (Dash 1991,
Srikanthamurthy 2001, Warrier et al 1994).
Constituents: Researchers have isolated a number
of triterpene glycosides from Ku¯s.ma¯n.d.
a, including
alnusenol and multiflorenol, as well as a flavonoid
C-glycoside, a benzyl glycoside, and -sitosterol.
Other constituents include proteins, sugars and fats,
as well as a cucumisin-like serine protease (Uchikoba
et al 1998, Yoganarasimhan 2000, Yoshizumi et al
1998).
Medical research:
In vivo: anti-ulcerogenic (Grover et al 2001); antiallergenic
(Grover et al 2001, Kumar & Ramu 2002,
Yoshizumi et al 1998); nootropic (Kumar & Nirmala
2003); anti-withdrawal (Grover et al 2000).
Toxicity: Chronic toxicity studies carried out for
3 months in experimental animals revealed no deleterious
effect of fresh juice of B. hispida on various
haematological and biochemical parameters (Grover
et al 2001).
Indications: Dyspepsia, colic, intestinal parasites, fever,
dry cough, purulent bronchitis, asthma, consumption,
wasting, oedema, thirst, burning sensations, haemorrhage,
urinary calculi, cystitis, leucorrhoea, epilepsy,
psychosis.
Contraindications: Diarrhoea (Bensky & Gamble
1993).
Medicinal uses: Ku¯s.ma¯n.d.
a is both a medicinal plant
and a vegetable, consumed widely throughout Asia. In
India Ku¯s.ma¯n.d.
a is highly valued as a nutritive food,
used during convalescence in wasting diseases,
and prepared as a confection in the treatment in ulceration
of the lungs and intestines. The fresh fruit of the
juice is used in haemoptysis and internal bleeding
(Nadkarni 1954). The Cakradatta recommends a
lehya called Va¯sa¯khan. daku¯s.ma¯n.d.
aka, prepared
from Ku¯s.ma¯n.d.
a pulp, Va¯saka and dı¯panapa¯cana
dravyas in the treatment of internal haemorrhaging,
chest wounds, cough, dyspnoea, consumption, angina
and back pain (Sharma 2002). In Chinese medicine
the seeds are similarly used in lung conditions with
a yellowish sputum, as well as in yellowish mucosal
discharges of the bowels and uterus (Bensky & Gamble
1993). Ku¯s.ma¯n.d.
a is also an important remedy in the
treatment of unma¯da (‘psychosis’) and apasma¯ra
Ku¯s.ma¯n.d.
a
BOTANICAL NAMES: Benincasa hispida, B. cerifera, Cucurbitaceae
OTHER NAMES: Petha, Kondha, Kudimah (H); Sambal pushani, Pushanikkai (T);
Wax Gourd, Winter Melon (E); Dong gua (C)
234 PART 2: A¯ yurvedic materia medica
(‘epilepsy’). The Cakradatta recommends the fresh
juices of Ku¯s.ma¯n.d.
a, Bra¯hmı¯, Vaca¯, ´San.khapus.pı¯ and
Kus.
t.
ha, taken with honey, in the treatment of unma¯da
(Sharma 2002). Similarly, the Bha¯vapraka¯´sa recommends
that 18 parts the fresh juice of Ku¯s.ma¯n.d.
a be
decocted in one part ghr. ta, with a paste of
Yas.t.
imadhu, down to one part ghr. ta, in the treatment
of apasma¯ra (Srikanthamurthy 2000). In the treatment
of difficult cases of intestinal colic the
Bha¯vapraka¯´sa recommends that the freshly dried
Ku¯s.ma¯n.d.
a fruit be heated until red hot over a mild fire,
reduced to a powder, and taken with a little ´Su¯n.t.
hı¯
(Srikanthamurthy 2000). In the treatment of cystitis
the Cakradatta recommends the fresh juice of
Ku¯s.ma¯n.d.
a with Yavaks.a¯ra and sugar (Sharma 2002).
Much like pumpkin seeds, the seeds of Ku¯s.ma¯n.d.
a are
consumed in the treatment of intestinal parasites.
Dosage:
Cu¯rn.
a: dried pulp and/or seed, 2–10 g b.i.d.–t.i.d.
Svarasa: 30–120 mL b.i.d.–t.i.d.
REFERENCES
Bensky D, Gamble A 1993 Chinese herbal medicine materia medica,
revised edn. Eastland Press, Seattle, p 135
Dash B 1991 Materia medica of Ayurveda. B Jain Publishers, New
Delhi, p 317–318
Grover JK, Rathi SS, Vats V 2000 Preliminary study of fresh juice of
Benincasa hispida on morphine addiction in mice. Fitoterapia
71(6):707–709
Grover JK, Adiga G, Vats V, Rathi SS 2001 Extracts of Benincasa
hispida prevent development of experimental ulcers. Journal of
Ethnopharmacology 78(2–3):159–164
Kapoor LD 1990 CRC Handbook of Ayurvedic medicinal plants. CRC
Press, Boca Raton
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1127
Kumar A, Nirmala V 2003 Nootropic activity of methanol extract of
Benincasa hispida fruit. Indian Journal of Pharmacy
35:194–201
Kumar A, Ramu P 2002 Effect of methanolic extract of Benincasa
hispida against histamine and acetylcholine induced bronchospasm
in guinea pigs. Indian Journal of Pharmacology
34:365–366
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay, p 186
Sharma PV 2002 Cakradatta: Sanskrit text with English translation.
Chaukhamba, Varanasi, p 130, 184
Srikanthamurthy KR 2000 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 2.
Krishnadas Academy, Varanasi, p 313, 426
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 388
Uchikoba T, Yonezawa H, Kaneda M 1998 Cucumisin like protease
from the sarcocarp of Benincasa hispida var. Ryukyu.
Phytochemistry 49(8):2215–2219
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1994 Indian medicinal
plants: a compendium of 500 species, vol 1. Orient
Longman, Hyderabad, p 261
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2: Tamil
Nadu. Self-published, Bangalore, p 75
Yoshizumi S, Murakami T, Kadoya M et al 1998 Medicinal
foodstuffs. XI. Histamine release inhibitors from wax gourd,
the fruits of Benincasa hispida Cogn. Yakugaku Zasshi
118(5):188–192
Kus.
t.
ha, ‘disease’ 235
Botany: Kus.
t.
ha is a robust erect perennial herb with
a stout stem attaining a height of up to 2 m, and roots
up to 60 cm long that have a distinctive, characteristic
odour. The leaves are membranous and irregularly
toothed, the basal leaves quite large, up to 1.2 m in
length, triangularly shaped with a winged stalk, the
terminal lobe up to 30 cm across. The upper leaves
arise from the stem and are smaller, with two clasping
lobes at the base. The bluish-purple flowers are borne
in axillary and terminal clusters, giving rise to compressed
achenes. Kus.
t.
ha is native to the Himalayas,
from Kashmir to Sikkim, northwards into Tibet and
eastwards into Yunnan province in China, between
elevations of 2500 and 4000 m. Kus.
t.
ha is currently
threatened with extinction due to unregulated harvesting
and is listed in CITES Appendix I (Kirtikar &
Basu 1935, MOPE 2001, Warrier et al 1996).
Part used: Root.
Dravygun. a:
Rasa: tikta, kat.u, madhura
Vipa¯ka: madhura
Vı¯rya: us.n.
a
Karma: dı ¯panapa¯cana, jvaraghna, chedana, ka¯sahara,
sva¯sahara, mu¯travirecana, raktaprasa¯dana,
kus.t.
haghna, vedana¯stha¯pana, stanyajanana,
vajı ¯karan. a, rasa¯yana, va¯takaphahara (Nadkarni
1954, Srikanthamurthy 2001, Warrier et al
1996).
Constituents: Kus.t.ha contains an essential oil used
in perfumery called costus oil, comprising upwards of
1.5% of the dried plant, that has a woody, musty, lingering
smell. Costus oil is composed mostly of
sesquiterpene lactones, including dihydrocostus lactone
(15%) and costos lactone (10%), other constituents
including aplotaxene (20%), -costen (6%),
-costen (6%), and costic acid (14%), and also smaller
amounts of camphene, phellandrene, caryophyllene
and selinene. Non-volatile constituents include amino
acid-sesquiterpene adducts saussureamines A–E, a
lignan glycoside, the alkaloid saussurine, a bitter principle,
a resin, tannin, fixed oil, inulin and sugar (De
Kraker et al 2001, Kapoor 1990, Lawless 1995,
Yoshikawa et al 1993).
Medical research:
In vitro: anti-inflammatory (Cho et al 2000,
Gokhale et al 2002, Matsuda et al 2003), anti-
HBsAg (Chen et al 1995), antitumour (Jeong et al
2002, Ko et al 2004, 2005).
In vivo: anti-ulcer (Yoshikawa et al 1993)
Human trials: in healthy volunteers a decoction
of Saussurea lappa was found to accelerate gastric
emptying and increase endogenous motilin release,
an amino acid peptide that regulates upper GI
motility (Chen et al 1994).
Toxicity: Costus oil isolated from Saussurea lappa is
associated with several cases of allergic contact dermatitis
(Cheminat et al 1981).
Indications: Dyspepsia, biliousness, gastrointestinal
spasm, diarrhoea, dysentery, fever, bronchitis,
asthma, skin diseases, dysmenorrhoea, muscle spasm,
gout, autotoxicity.
Contraindications: pittakopa. Bensky & Gamble
(1993) stated that Kus.
t.
ha is contraindicated in yin
deficiency and dryness.
Medicinal uses: The name Kus.
t.
ha refers to an
ancient Vedic plant god mentioned in the Atharva
veda as a remedy for takman, the archetypal disease
of excess or jvara (fever). In ancient India Kus.
t.
ha
was considered to be a divine plant derived from
Kus.
t.
ha, ‘disease’
BOTANICAL NAMES: Saussurea lappa, Aucklandia lappa, Asteraceae
OTHER NAMES: Kuth, Kur (H); Kostam, Goshtam (T); Costus (E); Mu xiang (C)
236 PART 2: A¯ yurvedic materia medica
heavenly sources, growing high in the Himalayas,
considered to be the brother of the divine Soma (Zysk
1998). From its Sanskrit name it could be inferred that
Kus.
t.
ha is a specific for skin disease (i.e. kus.t.
ha),
and indeed it is used as such, primarily as raktaprasa
¯dana, or alterative. Although it is not considered
among the most important plants in the
treatment of skin disease it is used in a variety of skin
conditions, from leprosy, ulcers and ringworm to leucoderma
and simple pruritis. More importantly,
Kus.
t.
ha is a rasa¯yana for va¯ta, helping to normalise
and strengthen digestion, cleanse the body of toxic
accumulations, enhance fertility and reduce pain. As
a bitter tasting herb Kus.
t.
ha acts on the liver and gall
bladder, stimulating bile synthesis and excretion, and
as an aromatic, acts as a carminative to ease cramping
and intestinal colic. Generally speaking, Kus.
t.
ha is an
important remedy in any kind of spasm or pain, be it
smooth or skeletal muscle, primarily due to its ability
to normalise va¯ta. In the treatment of cramping
and spasm of the abdomen or musculature the
Cakradatta recommends a topical preparation called
Kus.
t.
hadi taila, comprising taila and vinegar, mixed
with powders of Kus.
t.
ha and saindhava, and massaged
into the affected tissues (Sharma 2002). Mixed
with equal parts powders of Hin.gu, Trikat.u,
Yavaks.a¯ra and saindhava, Kus.
t.
ha is mixed with
Ma¯tulun.ga juice and taken internally to alleviate
abdominal pain (Sharma 2002). Similarly, Kus.
t.
ha is
used in Chinese medicine mixed with Bai zhu
(Atractylodes macrocephala) for epigastric pain and
bloating (Bensky & Gamble 1993). In the treatment of
diarrhoea and dysentery Kus.
t.
ha can be taken along
with Kut.aja, Harı¯takı¯, ´Su¯n.t.
hı¯, Mustaka, and
Da¯ruharidra¯. In the treatment of u¯rusthambha
(paraplegia), the Cakradatta recommends Kus.
t.
ha¯dya
taila, composed of Kus.
t.
ha, ´Srives.t.
aka resin,
Udı¯cya, Sarala wood, Devada¯ru, Na¯gake´sara,
Ajagandha¯ and A´svagandha¯ decocted in mustard
oil, taken internally with honey (Sharma 2002). In
the treatment of va¯ttika headache the ´Sa¯ran . gadhara
sam. hita¯ recommends a paste of Kus.
t.
ha cu¯rn.
a
prepared with rice water and castor oil, applied topically
(Srikanthamurthy 1984). In the treatment of
toothache, gum swelling and bleeding, Kus.
t.
ha is
mixed with equal parts Da¯rvı¯, Mañjis.t.
ha¯, Pa¯t.ha¯,
Kat.uka, Haridra¯, Tejanı¯, Mustaka and Lodhra,
and applied to the gums (Srikanthamurthy 1984).
In the treatment of va¯ttika udara roga in which
apa¯na va¯yu moves upwards, characterised by
abdominal bloating and pain, and accompanied by
joint pain, bodyache and lethargy, the Bha¯vapraka¯´sa
recommends Kus.
t.
hadi cu¯rn.
a, composed of equal
parts Kus.
t.
ha along with dı¯panapa¯cana remedies
such as Hin.gu, Cavya, Citraka and ´Su¯n.t.
hı¯
(Srikanthamurthy 2000). In the treatment of va¯ttika
anorexia, Kus.
t.
ha cu¯rn.
a is taken with equal parts
Sauvarcala (Sanchal salt), Jı¯raka, Marica, Vid.
a
(black salt) and sugar, with taila and honey as an
anupa¯na (Sharma 2002). In the treatment of
unma¯da (‘psychosis’), the Cakradatta recommends
a combination of equal parts Kus.
t.
ha with Bra¯hmı¯,
Ku¯s.ma¯n.d.
a, Vaca¯ and ´San.khapus.pı¯, taken with
honey (Sharma 2002). To keep children healthy and
strong, the Cakradatta recommends a lehya prepared
from equal parts Kus.
t.
ha, Vaca¯, Bra¯hmı¯, and
Svarn.
a (purified gold), prepared with honey and
ghr. ta, (Sharma 2002). As a refreshing mouth rinse,
the Cakradatta recommends Kus.
t.
hadi kavala,
comprised of equal parts infusion of Kus.
t.
ha,
Ela¯valuka, Ela¯, Mustaka, Dha¯nyaka and honey
(Sharma 2002). In the treatment of asthma, a tincture
of Kus.
t.
ha is stated to be particularly effective to
relieve bronchial spasm (Kirtikar & Basu 1935,
Nadkarni 1954).
Dosage:
Cu¯rn.
a: freshly dried root, 3–5 g b.i.d.–t.i.d.
Pha¯n.t.
a: freshly crushed root, 1:4, 30–60 mL
b.i.d.–t.i.d.
Tincture: freshly dried root, 1:4, 50% alcohol, 1–5
mL
REFERENCES
Bensky D, Gamble A 1993 Chinese herbal medicine materia medica,
revised edn. Eastland Press, Seattle, p 237–238
Cheminat A, Stampf JL, Benezra C et al 1981 Allergic contact dermatitis
to costus: removal of haptens with polymers. Acta
Dermato-Venereologica 61(6):525–529
Chen HC, Chou CK, Lee SD et al 1995 Active compounds from
Saussurea lappa Clarks that suppress hepatitis B virus surface
antigen gene expression in human hepatoma cells. Antiviral
Research 27(1–2):99–109
Chen SF, Li YQ, He FY 1994 Effect of Saussurea lappa on gastric
functions. Zhongguo Zhong Xi Yi Jie He Za Zhi
14(7):406–408
Cho JY, Baik KU, Jung JH, Park MH 2000 In vitro anti-inflammatory
effects of cynaropicrin, a sesquiterpene lactone, from
Saussurea lappa. European Journal of Pharmacology
398(3):399–407
Kus.
t.
ha, ‘disease’ 237
De Kraker JW, Franssen MC, De Groot A et al 2001 Germacrenes
from fresh costus roots. Phytochemistry 58(3):481–487
Gokhale AB, Damre AS, Kulkami KR, Saraf MN 2002 Preliminary
evaluation of anti-inflammatory and anti-arthritic activity of
S. lappa, A. speciosa and A. aspera. Phytomedicine
9(5):433–437
Jeong SJ, Itokawa T, Shibuya M et al 2002 Costunolide, a sesquiterpene
lactone from Saussurea lappa, inhibits the VEGFR
KDR/Flk–1 signaling pathway. Cancer Letters
187(1–2):129–133
Kapoor LD 1990 CRC handbook of Ayurvedic medicinal plants.
CRC Press, Boca Raton, p 300
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1420–1422
Ko SG, Koh SH, Jun CY et al 2004 Induction of apoptosis by
Saussurea lappa and Pharbitis nil on AGS gastric cancer cells.
Biological and Pharmaceutical Bulletin 27(10):1604–1610
Ko SG, Kim HP, Jin DH et al 2005 Saussurea lappa induces G2-
growth arrest and apoptosis in AGS gastric cancer cells. Cancer
Letters 220(1):11–19
Lawless J 1995 The illustrated encyclopedia of essential oils.
Element, Rockport MA, p 219
Matsuda H, Toguchida I, Ninomiya K et al 2003 Effects of
sesquiterpenes and amino acid-sesquiterpene conjugates from
the roots of Saussurea lappa on inducible nitric oxide synthase
and heat shock protein in lipopolysaccharide-activated
macrophages. Bioorganic and Medicinal Chemistry
11(5):709–715
MOPE 2001 Nepal’s State of the Environment. Ministry of
Population and Environment, Kathmandu p annex 1–2.
Available: http://www.mope.gov.np/environment/state2001.php
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay, p 1112
Sharma PV 2002 Cakradatta. Sanskrit text with English translation.
Chaukhamba, Varanasi, p 107, 165, 184, 245, 267, 595,
656
Srikanthamurthy KR 1984 ´Sa¯ran . gadhara sam. hita¯: a treatise on
Ayurveda. Chaukhamba Orientalia, Varanasi, p 235, 242
Srikanthamurthy KR 2000 Bha¯vapraka¯´sa of Bhavami´sra, vol. 2.
Krishnadas Academy, Varanasi, p 519
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 186,
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1996 Indian
medicinal plants: a compendium of 500 species, vol 5. Orient
Longman, Hyderabad, p 80–83
Yoshikawa M, Hatakeyama S, Inoue Y, Yamahara J 1993
Saussureamines A, B, C, D, and E, new anti-ulcer principles
from Chinese Saussureae Radix. Chemical and Pharmaceutical
Bulletin (Tokyo) 41(1):214–216
Zysk KG 1998 Asceticism and healing in ancient India: medicine in
the Buddhist monastery. Motilal Banarsidass, Delhi, p 19
238 PART 2: A¯ yurvedic materia medica
Botany: Kut.aja is a shrub or small tree with pale
coloured bark that exudes a whitish latex when cut.
The leaves are simple, broadly ovate to elliptic,
glabrous or pubescent, with 10–14 pairs of conspicuous
nerves, oppositely arranged on short petioles. The
flowers are white, without odour, borne in terminal
flat-topped cymes, giving rise to long narrow fruits
that are tipped with a crown of brown hairs. Kut.aja is
found throughout India and Southeast Asia, in deciduous
forests up to 900 m (Kirtikar & Basu 1935,
Warrier et al 1995).
Part used: Bark (Kut.aja), seeds (Indrayava).
Dravygun. a:
Rasa: ka´sa¯ya, tikta
Vipa¯ka: laghu
Vı¯rya: ´sita
Karma: dı ¯pana, chardinigrahan. a, purı ¯s.asangrahan. ı ¯ya,
kr . mighna, jvaraghna, ka¯sahara, sva¯sahara,
´son. itastha¯pana, kus.t.
haghna, kaphahara (Dash 1991,
Srikanthamurthy 2001, Warrier et al 1995).
Constituents: Researchers have isolated only a few
classes of constituents from Kut.aja, mostly
alkaloids, as well as steroidal alkaloids and steroids.
Among the alkaloidal constituents are conessine,
conessimine, kurchine, conamine, conimine, conessidine,
conarrhimine, holarrhimine, holarrhine and
kurchicine. Steroidal alkaloids include antidysentericine
and regholarrhenines A–F. Recently isolated
steroidal compounds include pubadysone, puboestrene
and pubamide. Other constituents include
-sitosterol, a triterpene alcohol, lupeol, gum, lettoresinols
A and B, and tannins (Kapoor 1990, Kumar
and Ali 2000, Siddiqui et al 2001, Williamson 2002,
Yoganarasimhan 2000).
Medical research:
In vitro: antibacterial (Aqil et al 2005, Chakraborty
& Brantner 1999, Kavitha et al 2004, Rani & Khullar
2004, Voravuthikunchai et al 2004).
In vivo: anti-amoebic, antidysentery (Duke 2002,
Williamson 2002); antidiarrhoeal (Kavitha et al
2004); immunomodulant (Atal et al 1986).
Toxicity: No data found.
Indications: Dyspepsia, diarrhoea, dysentery, amoebic
dysentery, intestinal parasites, haemorrhoids, fever,
malaria, asthma, pneumonia, jaundice, hepatosplenomegaly,
internal haemorrhaging, menorrhagia,
rheumatism, skin diseases.
Contraindications: Constipation, va¯takopa.
Medicinal uses: Kut.aja is an exceptionally important
and useful remedy in diarrhoea and dysentery,
and for this purpose the bark is preferred, which in
addition to containing antimicrobial alkaloids also
contains tannins that help to astringe the gut mucosa.
Among the best remedies to treat infectious diarrhoea
is Kut.aja aris.t.
a, a fermented preparation mentioned
in the Bhais.ajyaratna¯valı¯, taken in dosages of
12–24 mL in the treatment of dysentery, bloody
diarrhoea, malabsorptive syndromes, and fever
(India 1978). In the treatment of diarrhoea the
Cakradatta recommends a cu¯rn.
a composed of equal
parts Trikat.u, Indrayava, Nimba, Bhu¯nimba,
Bhr.n . gara¯ja, Citraka, Kat.uka, Pa¯t.ha¯, Da¯ruharidra¯
and purified Ativis.a¯, the total of which is mixed with
an equal quantity of Kut.aja, taken in doses of 3–5 g
with rice water or honey (Sharma 2002). Simpler formulations
mentioned by the Cakradatta include a
decoction of Indrayava, Kut.aja and Mustaka,
30–120 mL, taken with sugar and honey, or Kut.aja
and Da¯d.ima pericarp (Punica granatum) prepared as a
thick extract by decoction, taken in teaspoonful doses
Kut.
aja, ‘mountain born’
BOTANICAL NAMES: Holarrhena antidysenterica, H. pubescens, Apocynaceae
OTHER NAMES: Indrayava, ‘Indra’s seeds’ (S); Kurchi, Kuda (H); Kutashappalai,
Veppalai (T); Kurchi tree, Conessi tree (E)
Kut.aja, ‘mountain born’ 239
with buttermilk (Sharma 2002). In the treatment
of haemorrhoids the Cakradatta recommends
Kut.ajaleha, Kut.aja¯rasakriya¯, and Kut.aja¯dya
ghr. ta, the latter of which is prepared by medicating
ghr. ta with equal parts Kut.aja, Na¯gake´sara, Nı¯lotpala,
Lodhra, and Dha¯taki, taken in doses of 3–12 g
(Sharma 2002). Beyond its ability to check the secretions
of the digestive tract, Kut.aja is also widely used
as an antihaemorrhagic. In the treatment of menorrhagia
Kut.aja can be combined with herbs such as
Arjuna, Bilva and Nı¯lotpala, or non-Indian herbs
such as Shepherd’s Purse (Capsella bursa-pastoris) and
Cranesbill (Geranium maculatum). For pthisis and
tuberculosis Kut.aja can be used to check bleeding, in
combination with herbs such as Va¯saka, A¯malakı¯,
Pus.karamu¯la and Arjuna. Combined with equal
parts A¯malakı¯, Arjuna and Nimba, Kut.aja is taken
as a powder with honey for the paittika variants of
polyuria, indicated by polyuria with symptoms of
burning sensations, the urine coloured deep yellow to
red, with a pungent odour (Sharma 2002).
Dosage:
Cu¯rn.
a: bark and/or seed, 3–8 g b.i.d.–t.i.d.
Tincture: bark, 1:3, 70% alcohol, 2–5 mL
b.i.d.–t.i.d.
REFERENCES
Aqil F, Khan MS, Owais M, Ahmad I 2005 Effect of certain bioactive
plant extracts on clinical isolates of beta-lactamase producing
methicillin resistant Staphylococcus aureus. Journal of Basic
Microbiology 45(2):106–114
Atal CK, Sharma ML, Kaul A, Khajuria A 1986 Immunomodulating
agents of plant origin. I: Preliminary screening. Journal of
Ethnopharmacology 18(2):133–141
Chakraborty A, Brantner AH 1999 Antibacterial steroid alkaloids
from the stem bark of Holarrhena pubescens. Journal of
Ethnopharmacology 68(1–3):339–344
Dash B 1991 Materia medica of Ayurveda. B. Jain Publishers, New
Delhi, p 49
Duke JA 2002 Handbook of medicinal herbs, 2nd edn. CRC Press,
Boca Raton, p 219
India, Department of Health 1978 The Ayurvedic formulary of
India, Part 1. Controller of Publications, Delhi, p 7
Kapoor LD 1990 CRC handbook of Ayurvedic medicinal plants.
CRC Press, Boca Raton, p 205–206
Kavitha D, Shilpa PN, Devaraj SN 2004 Antibacterial and antidiarrhoeal
effects of alkaloids of Holarrhena antidysenterica
WALL. Indian Journal of Experimental Biology 42(6):589–594
Kirtikar KR, Basu BD 1935 Indian medicinal plants, 2nd edn, vols
1–4. Periodical Experts, Delhi, p 1570
Kumar A, Ali M 2000 A new steroidal alkaloid from the seeds of
Holarrhena antidysenterica. Fitoterapia 71(2):101–104
Nadkarni KM 1954 The Indian materia medica, with Ayurvedic,
Unani and home remedies, revised and enlarged by A.K.
Nadkarni. Popular Prakashan PVP, Bombay
Rani P, Khullar N 2004 Antimicrobial evaluation of some medicinal
plants for their anti-enteric potential against multi-drug
resistant Salmonella typhi. Phytotherapy Research
18(8):670–673
Sharma PV 2002 Cakradatta: Sanskrit text with English translation.
Chaukhamba, Varanasi, p 47, 53, 90, 326
Siddiqui BS, Usmani SB, Ali ST et al 2001 Further constituents from
the bark of Holarrhena pubescens. Phytochemistry
58(8):1199–1204
Srikanthamurthy KR 2001 Bha¯vapraka¯´sa of Bha¯vami´sra, vol 1.
Krishnadas Academy, Varanasi, p 183, 245
Voravuthikunchai S, Lortheeranuwat A, Jeeju W et al 2004
Effective medicinal plants against enterohaemorrhagic
Escherichia coli O157:H7. Journal of Ethnopharmacology
94(1):49–54
Warrier PK, Nambiar VPK, Ramankutty C (eds) 1995 Indian
medicinal plants: a compendium of 500 species, vol 3. Orient
Longman, Hyderabad, p 156
Williamson EM (ed) 2002 Major herbs of Ayurveda. Churchill
Livingstone, London, p 173
Yoganarasimhan SN 2000 Medicinal plants of India, vol 2: Tamil
Nadu. Self-published, Bangalore, p 272
 





Om Tat Sat
                                                        
(Continued...) 



(My humble salutations to   Sreeman Todd Caldecott, Elsevier’s Health Sciences and others other eminent medical scholars and doctors   for the collection)


0 comments:

Post a Comment